Enagás and SATLANTIS Start Microsatellite Camera Calibration Tests To Detect Emissions
Enagás and SATLANTIS, a UF startup and UF Innovate | The Hub resident company specializing in high-performance optical loads for observation of the Earth for small satellites, are carrying out high-precision optics calibration tests, which will be inserted into a constellation of space microsatellites, known by the acronym GEISAT (Greenhouse Gases), to detect and quantify methane emissions on Earth.
AGTC Announces Expansion of Manufacturing and Analytics Capabilities to Advance Commercialization of Gene Therapy Product Candidates
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that it has initiated plans to lease a build-to-suit 21,000 square foot current Good Manufacturing Practices (cGMP) manufacturing and quality control facility adjacent to its Florida facility to prepare for anticipated late-stage development of its X-Linked Retinitis Pigmentosa (XLRP) and Achromatopsia (ACHM) programs.
Cannabix Technologies Receives Notice of Allowance for Detection of Molecules – FAIMS U.S. Patent
UF startup Cannabix Technologies Inc., developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, reports that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for patent application No. 17/019728 entitled, “Apparatus and Methods for Detection of Molecules”.
Genascence Announces Completion of Dosing and Interim Safety Data for Phase 1 Clinical Trial of GNSC-001 in Osteoarthritis
Genascence Corporation, a clinical-stage biotechnology company developing life-changing gene therapy products for prevalent musculoskeletal diseases, announced that dosing across all three cohorts has been completed in Phase 1 clinical trial of GNSC-001 for the treatment of osteoarthritis (OA).
How Shark Scales’ Unique Design Inspired the First Manmade Pattern to Help Stop Bacterial Spread
UF startup and UF Innovate | Sid Martin Biotech alum Sharklet Technologies Inc. is featured in Business Insider for its novel, breakthrough technology that inhibits bacteria growth and even limits touch transfer of viruses, reducing the transmission of harmful microorganisms.
Rafael Guzmán, SATLANTIS’ CTO, Featured on The Space Industry Podcast
Rafael Guzmán, founder and CTO of UF startup and UF Innovate | The Hub resident SATLANTIS, a Spanish business that develops Earth Observation (EO) optical payloads for small satellites around the world, is featured on The Space Industry podcast by Sat Search.
CROs dMed and Clinipace Merge To Accelerate Customer Success
dMed Global, a full-service Clinical Contract Research Organization (CRO) based in Shanghai, China, and UF startup Clinipace Incorporated, a full-service clinical CRO with headquarters in North Carolina, USA, announced that the two companies will merge.
Florida High Tech Corridor Incubators Experience Startup Surge
Florida native and CEO of Agriculture Intelligence Matt Donovan has discovered a “renewed environment with a fertile ground for talent.” A resident company in UF Innovate | The Hub, Agriculture Intelligence is a precision agriculture science company combining machine vision, machine learning and artificial intelligence to provide cloud-based, precision data for specialty crops.
Cannabix Technologies Receives Notice of Allowance for Cannabis Drug Detection Device Canadian Patent
UF startup Cannabix Technologies Inc., developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, reports that it has received a notice of allowance from the Canadian Intellectual Property Office (CIPO) for its 2015 licensed patent application, No. 2887841 entitled, “Cannabis Drug Detection Device”.
AGTC Licenses Promoter Technology to SparingVision SAS
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced a licensing agreement that provides its proprietary cone-specific promoter technology to SparingVision SAS, a genomic medicine company developing vision-saving treatments for ocular diseases.
